Atlas Trials

Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects

Clinical trial NCT03149848 · COMPLETED

Trial details

NCT number
NCT03149848
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Infection, Human Immunodeficiency VirusHIV Infections
Start date
2017-06-06
Primary completion
2017-09-06
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.